Prevalence of Metabolic Syndrome in Patients with Mucosal Lichen Planus: A Case–Control Study

American Journal of Clinical Dermatology

Volumn 16, Issue 5, 2015, Pages 439-445

  Baykal, Leyla ^a   Arıca, Deniz Aksu ^b   Yaylı, Savaş ^b   Örem, Asım ^b   Bahadır, Sevgi ^b   Altun, Ece ^b   Yaman, Hüseyin ^b  

^a Artvin State Hospital   (Turkey)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; YOUNG ADULT; BLOOD; BODY MASS; DYSLIPIDEMIAS; HYPERTENSION; LICHEN PLANUS, ORAL; METABOLISM; ONSET AGE; PATHOLOGY; PREVALENCE; TIME FACTOR;

ADULT; AGE OF ONSET; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LICHEN PLANUS, ORAL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; PROSPECTIVE STUDIES; TIME FACTORS; TRIGLYCERIDES;

EID: 84942307942     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.1007/s40257-015-0142-8     Document Type: Article

References (28)

1. Wagner G, Rose C, Sachse MM. Clinical variants of lichen planus. J Dtsch Dermatol Ges. 2013;11:309–19.
2. Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007;157:68–73.
3. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829–35.
4. Mallbris L, Ritchlin CT, Stahle M. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep. 2006;8:355–63.
5. Prodanovich S, Shelling ML, Federman DG, Kirsner RS. Cytokine milieu in psoriasis and cardiovascular disease may explain the epidemiological findings relating these 2 diseases. Arch Dermatol. 2008;144:1518–9.
6. Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol. 2009;145:700–3.
7. Dreiher J, Shapiro J, Cohen AD. Lichen planus and dyslipidaemia: a case-control study. Br J Dermatol. 2009;161:626–9.
8. Arias-Santiago S, Buendia-Eisman A, Aneiros-Fernandez J, Girón-Prieto MS, Gutiérrez-Salmerón MT, García-Mellado V, et al. Lipid levels in patients with lichen planus: a case-control study. J Eur Acad Dermatol Venereol. 2011;25:1398–401.
9. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis. 2007;190:1–9.
10. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–28.
11. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs. Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005;165:2644–50.
12. Powell SM, Ellis JP, Ryan TJ, Vickers HR. Glucose tolerance in lichen planus. Br J Dermatol. 1974;91:73–5.
13. Arias-Santiago S, Buendia-Eisman A, Aneiros-Fernandez J, Girón-Prieto MS, Gutiérrez-Salmerón MT, Mellado VG, et al. Cardiovascular risk factors in patients with lichen planus. Am J Med. 2011;124:543–8.
14. Saleh N, Samir N, Megahed H, Farid E. Homocysteine and other cardiovascular risk factors in patients with lichen planus. J Eur Acad Dermatol Venereol. 2014;28:1507–13.
15. National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421.
16. Erem C, Hacihasanoglu A, Deger O, Topbaş M, Hosver I, Ersoz HO, et al. Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocrine. 2008;33:9–20.
17. Padhi T, Garima. Metabolic syndrome and skin: psoriasis and beyond. Indian J Dermatol. 2013;58:299–305.
18. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008;93:64–73.
19. Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem. 2008;19:491–504.
20. Hulthe J, Hultén LM, Fagerberg B. Low adipocyte-derived plasmaprotein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism. 2003;52:1612–4.
21. Shiora T, Kano Y. Lichen planus and lichenoid dermatosis. In: Bolognia JL, Borizzo JL, Rapini RP (eds). General dermatology, 2nd edn. Mosby; 2008, p. 159–170.
22. Aly DG, Shahin RS. Oxidative stress in lichen planus. Acta Dermatovenerol Alp Pannonica Adriat. 2010;19:3–11.
23. Sezer E, Ozugurlu F, Ozyurt H, Sahin S, Etikan I. Lipid peroxidation and antioxidant status in lichen planus. Clin Exp Dermatol. 2007;32:430–4.
24. Meller S, Gilliet M, Homey B. Chemokines in the pathogenesis of lichenoid tissue reactions. J Invest Dermatol. 2009;129:315–9.
25. Spah F. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol. 2008;159:10–7.
26. Lopez-Jornet P, Camacho-Alonso F, Rodriguez-Martines MA. Alterations in serum lipid profile patterns in oral lichen planus: a cross-sectional study. Am J Clin Dermatol. 2012;13:399–404.
27. Tablazon IL, Al-Dabagh A, Davis SA, Feldman SR. Risk of cardiovascular disorders in psoriasis patients: current and future. Am J Clin Dermatol. 2013;14:1–7.
28. Chedraui P, San Miguel G, Vintimilla-Sigüenza I, Villacreses D, Romero-Huete L, Domínguez A, Research Group for Omega Women’s Health Project, et al. The metabolic syndrome and its components in postmenopausal women. Gynecol Endocrinol. 2013;29:563–8.